Intensivmedizin up2date 2014; 10(01): 61-74
DOI: 10.1055/s-0034-1364874
Operative Intensivmedizin
© Georg Thieme Verlag KG Stuttgart · New York

Perioperativer Myokardinfarkt

Oliver Spelten
,
Volker Rudolph
Further Information

Publication History

Publication Date:
11 February 2014 (online)

Kernaussagen
  • Kardiovaskuläre Komplikationen bedeuten bei Operationen ein großes Risiko für den Patienten. Insbesondere der perioperative Myokardinfarkt (POMI) ist mit einer hohen Mortalität verbunden, da er häufig kaum klinisch fassbare Symptome bietet und daher erst spät erkannt und behandelt wird.

  • Typische Auslöser eines POMI sind eine Plaqueruptur mit nachfolgendem Koronargefäßverschluss oder ein Missverhältnis zwischen Sauerstoffangebot und Sauerstoffbedarf durch den operativen Stress und/oder hypoxische Phasen unterschiedlicher Genese.

  • Wichtig ist die präoperative Risikoeinschätzung, um perioperativ gefährdende Situationen zu vermeiden und die wenigen klinisch fassbaren Zeichen einer Myokardischämie zu identifizieren.

  • Beim klinischen Verdacht auf einen POMI sind eine umgehende Diagnostik mit EKG und Troponinbestimmung sowie eine Therapie in enger interdisziplinärer Absprache erforderlich.

  • Bei einem STEMI oder einem NSTEMI mit hämodynamischer Instabilität ist eine Katheterintervention mit Reperfusionsmöglichkeit anzustreben, beim NSTEMI ohne hämodynamische Instabilität steht die konservative Therapie im Vordergrund.

Die Literatur zu diesem Beitrag finden Sie unter http://dx.doi.org/10.1055/s-0034-1364874.

 
  • Literatur

  • 1 Weiser TG, Regenbogen SE, Thompson KD et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008; 372: 139-144
  • 2 Brady AR, Gibbs JS, Greenhalgh RM et al. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. Journal of Vascular Surgery 2005; 41: 602-609
  • 3 Lindenauer PK, Pekow P, Wang K et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005; 353: 349-361
  • 4 Landesberg G, Beattie WS, Mosseri M et al. Perioperative myocardial infarction. Circulation 2009; 119: 2936-2944
  • 5 Devereaux PJ, Xavier D, Pogue J et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Annals of Internal Medicine 2011; 154: 523-528
  • 6 Wu WC, Schifftner TL, Henderson WG et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007; 297: 2481-2488
  • 7 Ashton CM, Petersen NJ, Wray NP et al. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Annals of Internal Medicine 1993; 118: 504-510
  • 8 Badner NH, Knill RL, Brown JE et al. Myocardial infarction after noncardiac surgery. Anesthesiology 1998; 88: 572-578
  • 9 Kumar R, Mckinney WP, Raj G et al. Adverse cardiac events after surgery: assessing risk in a veteran population. Journal of General Internal Medicine 2001; 16: 507-518
  • 10 Shah KB, Kleinman BS, Rao TL et al. Angina and other risk factors in patients with cardiac diseases undergoing noncardiac operations. Anesthesia and Analgesia 1990; 70: 240-247
  • 11 Adams 3rd JE, Sicard GA, Allen BT et al. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med 1994; 330: 670-674
  • 12 Bursi F, Babuin L, Barbieri A et al. Vascular surgery patients: perioperative and long-term risk according to the ACC/AHA guidelines, the additive role of post-operative troponin elevation. Eur Heart J 2005; 26: 2448-2456
  • 13 Landesberg G, Shatz V, Akopnik I et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. J Am Coll Cardiol 2003; 42: 1547-1554
  • 14 Le Manach Y, Perel A, Coriat P et al. Early and delayed myocardial infarction after abdominal aortic surgery. Anesthesiology 2005; 102: 885-891
  • 15 Thygesen K, Alpert JS, Jaffe AS et al. Third universal definition of myocardial infarction. Circulation 2012; 126: 2020-2035
  • 16 Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. British Heart Journal 1983; 50: 127-134
  • 17 Horie T, Sekiguchi M, Hirosawa K. Coronary thrombosis in pathogenesis of acute myocardial infarction. Histopathological study of coronary arteries in 108 necropsied cases using serial section. British Heart Journal 1978; 40: 153-161
  • 18 Chapman I. Relationships of recent coronary artery occlusion and acute myocardial infarction. Journal of the Mount Sinai Hospital, New York 1968; 35: 149-154
  • 19 Davies MJ, Woolf N, Robertson WB. Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi. British Heart Journal 1976; 38: 659-664
  • 20 Sinapius D. Relationship between coronary-artery thrombosis and myocardial infarction. DMW 1972; 97: 443-448
  • 21 Cohen MC, Aretz TH. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovascular Pathology 1999; 8: 133-139
  • 22 Dawood MM, Gutpa DK, Southern J et al. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. International journal of cardiology 1996; 57: 37-44
  • 23 Hanson I, Kahn J, Dixon S et al. Angiographic and clinical characteristics of type 1 versus type 2 perioperative myocardial infarction. Catheterization and cardiovascular interventions: official journal of the Society for Cardiac Angiography & Interventions 2012;
  • 24 Landesberg G, Mosseri M, Zahger D et al. Myocardial infarction after vascular surgery: the role of prolonged stress-induced, ST depression-type ischemia. J Am Coll Cardiol 2001; 37: 1839-1845
  • 25 Rapp HJ, Rabethge S, Luiz T et al. Perioperative ST-segment depression and troponin T release. Identification of patients with highest risk for myocardial damage. Acta anaesthesiologica Scandinavica 1999; 43: 124-129
  • 26 Reichlin T, Schindler C, Drexler B et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Archives of internal medicine 2012; 172: 1211-1218
  • 27 Weber M, Hamm C. Redefinition of myocardial infarction – relevance of biomarkers. Herz 2008; 33: 115-121
  • 28 Gerhardt W, Ljungdahl L. Troponin T: a sensitive and specific diagnostic and prognostic marker of myocardial damage. Clinica chimica acta 1998; 272: 47-57
  • 29 Howell SJ, Thompson JP, Nimmo AF et al. Relationship between perioperative troponin elevation and other indicators of myocardial injury in vascular surgery patients. Br J of Anesthesia 2006; 96: 303-309
  • 30 Landesberg G, Mosseri M, Shatz V et al. Cardiac troponin after major vascular surgery: the role of perioperative ischemia, preoperative thallium scanning, and coronary revascularization. J Am Coll Cardiol 2004; 44: 569-575
  • 31 La Vecchia L, Ottani F, Favero L et al. Increased cardiac troponin I on admission predicts in-hospital mortality in acute pulmonary embolism. Heart 2004; 90: 633-637
  • 32 Wu AH. Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression?. Intensive Care Med 2001; 27: 959-961
  • 33 Roongsritong C, Warraich I, Bradley C. Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance. Chest 2004; 125: 1877-1884
  • 34 Kim LJ, Martinez EA, Faraday N et al. Cardiac troponin I predicts short-term mortality in vascular surgery patients. Circulation 2002; 106: 2366-2371
  • 35 Levy M, Heels-Ansdell D, Hiralal R et al. Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and meta-analysis. Anesthesiology 2011; 114: 796-806
  • 36 Oscarsson A, Eintrei C, Anskar S et al. Troponin T-values provide long-term prognosis in elderly patients undergoing non-cardiac surgery. Acta Anaesthesiologica Scandinavica 2004; 48: 1071-1079
  • 37 Devereaux PJ, Chan MT et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA 2012; 307: 2295-2304
  • 38 Landesberg G, Vesselov Y, Einav S et al. Myocardial ischemia, cardiac troponin, and long-term survival of high-cardiac risk critically ill intensive care unit patients. Crit Care Med 2005; 33: 1281-1287
  • 39 Quenot JP, Le Teuff G, Quantin C et al. Myocardial injury in critically ill patients: relation to increased cardiac troponin I and hospital mortality. Chest 2005; 128: 2758-2764
  • 40 De Lemos JA, Drazner MH, Omland T et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010; 304: 2503-2512
  • 41 Roggenbach J, Bottiger BW, Teschendorf P. Perioperative myocardial damage in non-cardiac surgery patients. Anaesthesist 2009; 58: 665-676
  • 42 Carson JL, Terrin ML, Noveck H et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365: 2453-2462
  • 43 Group PS, Devereaux PJ, Yang H et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008; 371: 1839-1847
  • 44 Van Waes JA, Nathoe HM, De Graaff JC et al. Myocardial injury after noncardiac surgery and its association with short-term mortality. Circulation 2013; 127: 2264-2271
  • 45 Heeschen C, Hamm CW, Mitrovic V et al. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004; 110: 3206-3212
  • 46 Schnabel R, Lubos E, Rupprecht HJ et al. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study. J Am Coll Cardiol 2006; 47: 552-558
  • 47 Chong CP, Lim WK, Velkoska E et al. N-terminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic surgery. Am J Cardiol 2012; 109: 1365-1373
  • 48 Landesberg G, Mosseri M, Wolf Y et al. Perioperative myocardial ischemia and infarction: identification by continuous 12-lead electrocardiogram with online ST-segment monitoring. Anesthesiology 2002; 96: 264-270
  • 49 Higham H, Sear JW, Neill F et al. Peri-operative silent myocardial ischaemia and long-term adverse outcomes in non-cardiac surgical patients. Anesthesia 2001; 56: 630-637
  • 50 Bottiger BW, Motsch J, Teschendorf P et al. Postoperative 12-lead ECG predicts peri-operative myocardial ischaemia associated with myocardial cell damage. Anesthesia 2004; 59: 1083-1090
  • 51 Fleisher LA. Real-time intraoperative monitoring of myocardial ischemia in noncardiac surgery. Anesthesiology 2000; 92: 1183-1188
  • 52 Howell SJ, Hemming AE, Allman KG et al. Predictors of postoperative myocardial ischaemia. The role of intercurrent arterial hypertension and other cardiovascular risk factors. Anesthesia 1997; 52: 107-111
  • 53 Mangano DT, Browner WS, Hollenberg M et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 1990; 323: 1781-1788
  • 54 Van Mieghem C, Sabbe M, Knockaert D. The clinical value of the ECG in noncardiac conditions. Chest 2004; 125: 1561-1576
  • 55 Fleisher LA, Zielski MM, Schulman SP. Perioperative ST-segment depression is rare and may not indicate myocardial ischemia in moderate-risk patients undergoing noncardiac surgery. Journal of cardiothoracic and vascular anesthesia 1997; 11: 155-159
  • 56 Marsch SC, Schaefer HG, Skarvan K et al. Perioperative myocardial ischemia in patients undergoing elective hip arthroplasty during lumbar regional anesthesia. Anesthesiology 1992; 76: 518-527
  • 57 Windsor A, French GW, Sear JW et al. Silent myocardial ischaemia in patients undergoing transurethral prostatectomy. A study to evaluate risk scoring and anaesthetic technique with outcome. Anesthesia 1996; 51: 728-732
  • 58 Poldermans D, Bax JJ, Boersma E et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur J of Anesthesiology 2010; 27: 92-137
  • 59 Alcock RF, Kouzios D, Naoum C et al. Perioperative myocardial necrosis in patients at high cardiovascular risk undergoing elective non-cardiac surgery. Heart 2012; 98: 792-798
  • 60 Sprung J, Abdelmalak B, Gottlieb A et al. Analysis of risk factors for myocardial infarction and cardiac mortality after major vascular surgery. Anesthesiology 2000; 93: 129-140
  • 61 Poldermans D, Boersma E, Bax JJ et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341: 1789-1794
  • 62 Juul AB, Wetterslev J, Gluud C et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 2006; 332: 1482
  • 63 Yang H, Raymer K, Butler R et al. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J 2006; 152: 983-990
  • 64 Weiskopf RB, Feiner J, Hopf H et al. Heart rate increases linearly in response to acute isovolemic anemia. Transfusion 2003; 43: 235-240
  • 65 Fleisher LA, Beckman JA, Brown KA et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery. Circulation 2007; 116: 1971-1996
  • 66 London MJ. Quo vadis, perioperative beta blockade? Are you “POISE’d” on the brink?. Anesthesia and Analgesia 2008; 106: 1025-1030
  • 67 Wijeysundera DN, Naik JS, Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J of Medicine 2003; 114: 742-752
  • 68 Wijeysundera DN, Beattie WS. Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesthesia and Analgesia 2003; 97: 634-641
  • 69 Le Manach Y, Godet G, Coriat P et al. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesthesia and Analgesia 2007; 104: 1326-1333
  • 70 Sanders RD, Nicholson A, Lewis SR et al. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery. The Cochrane database of systematic reviews 2013; 7 CD009971
  • 71 American Society of Anesthesiologists. Practice alert for the perioperative management of patients with coronary artery stents: a report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology 2009; 110: 22-23
  • 72 Eisenberg MJ, Richard PR, Libersan D et al. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation 2009; 119: 1634-1642
  • 73 Alshawabkeh LI, Prasad A, Lenkovsky F et al. Outcomes of a preoperative “bridging” strategy with glycoprotein IIb/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration. EuroIntervention 2013; 9: 204-211
  • 74 Rodriguez LA, Cea-Soriano L, Martin-Merino E et al. Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care. BMJ 2011; 343: 4094
  • 75 Deutsche Gesellschaft für Anasthesiologie, Deutsche Gesellschaft für Innere Medizin, Deutsche Gesellschaft für Chirurgie. Preoperative evaluation of adult patients prior to elective, non-cardiac surgery. Anaesthesist 2010; 59: 1041-1050
  • 76 Deans KJ, Minneci PC, Suffredini AF et al. Randomization in clinical trials of titrated therapies: unintended consequences of using fixed treatment protocols. Crit Care Med 2007; 35: 1509-1516
  • 77 Rao SV, Jollis JG, Harrington RA et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292: 1555-1562
  • 78 Taylor RW, O’Brien J, Trottier SJ et al. Red blood cell transfusions and nosocomial infections in critically ill patients. Crit Care Med 2006; 34: 2302-2308
  • 79 O’gara PT, Kushner FG, Ascheim DD et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. Circulation 2013; 127: e362-425
  • 80 Jneid JL, Anderson RS, Wright RS et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction. Circulation 2012; 126: 875-910
  • 81 Carson JL, Brooks MM, Abbott JD et al. Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. Am Heart J 2013; 165: 964-971
  • 82 Lee TH, Marcantonio ER, Mangione CM et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-1049